The DOJ had been investigating the off-label use of Infuse. Physicians are able to use products off label, but companies cannot promote off-label use.
More Articles on Orthopedic Devices:
Future of Orthopedic Instrumentation Industry Examined in New Report
20 Orthopedic Device Company Q1 Financial Report Updates
Mazor Revenue Up in Q1 After 3 Robotic Spine System Sales
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
